Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. par Garcia-Carbonero, R, Salazar, R, Duran, I, Osman-Garcia, I, Paz-Ares, L, Bozada, J, Boni, V, Blanc, C, Seymour, L, Beadle, J, Alvis, S, Champion, B, Calvo, E, Fisher, K